Please enable JavaScript to continue using this application.

Compare $CDNA vs $IDYA | Chartloom

Compare

$CDNA vs $IDYA

CareDx Inc · IDEAYA Biosciences Inc

CDNA

CareDx Inc

IDYA

IDEAYA Biosciences Inc

Compare $CDNA vs $IDYA

Comparing CareDx Inc and IDEAYA Biosciences Inc

CDNACareDx Inc

IDYAIDEAYA Biosciences Inc

CDNACareDx Inc

Market cap

$3.29B

P/E (TTM)

30.64x

Forward P/E (NTM)

57.50x

Forward P/S (NTM)

6.55x

Rev growth (TTM)

34.4%

YTD performance

232.7%

52W performance

330.5%

FCF yield

2.6%

IDYAIDEAYA Biosciences Inc

Market cap

$3.43B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

59.38x

Rev growth (TTM)

3244.7%

YTD performance

6.7%

52W performance

34.5%

FCF yield

-3.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CDNA

IDYA

Detailed metrics comparison

CDNA

CareDx Inc

IDYA

IDEAYA Biosciences Inc

Market Cap

CDNA$3.29B

IDYA$3.43B

Enterprise Value

CDNA$2.92B

IDYA$3.16B

Price

CDNA$63.67

IDYA$36.11

P/E Ratio

CDNA30.64x

IDYAN/A

P/S Ratio

CDNA7.18x

IDYA14.66x

EV/Sales

CDNA6.36x

IDYA13.50x

EV/EBITDA

CDNA23.24x

IDYA0.00x

P/B Ratio

CDNA8.16x

IDYA3.01x

P/FCF Ratio

CDNA39.14x

IDYAN/A

EV/FCF

CDNA34.70x

IDYA-27.76x

PEG Ratio

CDNA0.31x

IDYAN/A

Forward P/E (NTM)

CDNA57.50x

IDYAN/A

Forward P/S (NTM)

CDNA6.55x

IDYA59.38x

Revenue (TTM)

CDNA$458M

IDYA$234M

Revenue Growth (YoY)

CDNA34.4%

IDYA3244.7%

Forward Rev Growth

CDNA7.0%

IDYA218.2%

Gross Margin (TTM)

CDNA70.6%

IDYA0.0%

Operating Margin (TTM)

CDNA23.6%

IDYA0.0%

EBITDA Margin (TTM)

CDNA27.4%

IDYA-91.5%

Net Margin (TTM)

CDNA24.2%

IDYA-74.8%

FCF Margin (TTM)

CDNA18.3%

IDYA-48.6%

Net Income (TTM)

CDNA$111M

IDYA$-175M

FCF (TTM)

CDNA$84M

IDYA$-114M

EPS (TTM)

CDNA$2.08

IDYA-$1.90

ROE (TTM)

CDNA32.8%

IDYA-1647.0%

ROA (TTM)

CDNA24.8%

IDYA-1511.0%

ROIC (TTM)

CDNA32.8%

IDYA-1647.0%

Cash

CDNA$374M

IDYA$273M

Debt

CDNA$0

IDYA$0

Net Cash/Debt

CDNA$374M

IDYA$273M

Current Ratio (TTM)

CDNA4.58x

IDYA10.45x

Quick Ratio (TTM)

CDNA4.35x

IDYA10.21x

Debt/Equity (TTM)

CDNA0.00x

IDYA0.00x

Debt/Assets (TTM)

CDNA0.0%

IDYA0.0%

Interest Coverage (TTM)

CDNAN/A

IDYAN/A

Net Debt/EBITDA (TTM)

CDNA0.00x

IDYA0.00x

Beta

CDNA2.58

IDYA0.04

52W Performance

CDNA330.5%

IDYA34.5%

YTD Performance

CDNA232.7%

IDYA6.7%

% from 52W High

CDNA-12.2%

IDYA-15.4%

% from 52W Low

CDNA356.4%

IDYA38.6%

Asset Turnover (TTM)

CDNA1.02x

IDYA0.20x

FCF Yield (TTM)

CDNA2.6%

IDYA-3.3%

Earnings Yield (TTM)

CDNA3.4%

IDYA-5.1%

Dividend Yield (TTM)

CDNAN/A

IDYAN/A

Rule of 40

CDNA52.7

IDYA3,196.0

EV/GP/RG

CDNA0.94

IDYAN/A

Ticker research

View CDNA research View IDYA research

Metric	CDNA CareDx Inc	IDYA IDEAYA Biosciences Inc
Market & Valuation
Market Cap	$3.29B	$3.43B
Enterprise Value	$2.92B	$3.16B
Price	$63.67	$36.11
P/E Ratio	30.64x	N/A
P/S Ratio	7.18x	14.66x
EV/Sales	6.36x	13.50x
EV/EBITDA	23.24x	0.00x
P/B Ratio	8.16x	3.01x
P/FCF Ratio	39.14x	N/A
EV/FCF	34.70x	-27.76x
PEG Ratio	0.31x	N/A
Forward P/E (NTM)	57.50x	N/A
Forward P/S (NTM)	6.55x	59.38x
Revenue & Growth
Revenue (TTM)	$458M	$234M
Revenue Growth (YoY)	34.4%	3244.7%
Forward Rev Growth	7.0%	218.2%
Profitability
Gross Margin (TTM)	70.6%	0.0%
Operating Margin (TTM)	23.6%	0.0%
EBITDA Margin (TTM)	27.4%	-91.5%
Net Margin (TTM)	24.2%	-74.8%
FCF Margin (TTM)	18.3%	-48.6%
Net Income (TTM)	$111M	$-175M
FCF (TTM)	$84M	$-114M
EPS (TTM)	$2.08	-$1.90
ROE (TTM)	32.8%	-1647.0%
ROA (TTM)	24.8%	-1511.0%
ROIC (TTM)	32.8%	-1647.0%
Financial Health
Cash	$374M	$273M
Debt	$0	$0
Net Cash/Debt	$374M	$273M
Current Ratio (TTM)	4.58x	10.45x
Quick Ratio (TTM)	4.35x	10.21x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.58	0.04
52W Performance	330.5%	34.5%
YTD Performance	232.7%	6.7%
% from 52W High	-12.2%	-15.4%
% from 52W Low	356.4%	38.6%
Efficiency & Yields
Asset Turnover (TTM)	1.02x	0.20x
FCF Yield (TTM)	2.6%	-3.3%
Earnings Yield (TTM)	3.4%	-5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	52.7	3,196.0
EV/GP/RG	0.94	N/A
Ticker research	View CDNA research	View IDYA research

Valuation

P/E Ratio

CDNA

30.64x

P/S Ratio

CDNA

7.18x

IDYA

14.66x

EV/FCF

IDYA

-27.76x

CDNA

34.70x

Growth & revenue

Revenue Growth TTM

IDYA

3244.7%

CDNA

34.4%

Forward Revenue Growth

IDYA

218.2%

CDNA

7.0%

Profitability & performance

Gross Margin

CDNA

70.6%

IDYA

0.0%

ROE

CDNA

32.8%

IDYA

-1647.0%

FCF Yield %

CDNA

2.6%

IDYA

-3.3%

52-Week Performance

CDNA

330.5%

IDYA

34.5%

Detailed metrics comparison

CDNA

CareDx Inc

IDYA

IDEAYA Biosciences Inc

Market Cap

CDNA$3.29B

IDYA$3.43B

Enterprise Value

CDNA$2.92B

IDYA$3.16B

Price

CDNA$63.67

IDYA$36.11

P/E Ratio

CDNA30.64x

IDYAN/A

P/S Ratio

CDNA7.18x

IDYA14.66x

EV/Sales

CDNA6.36x

IDYA13.50x

EV/EBITDA

CDNA23.24x

IDYA0.00x

P/B Ratio

CDNA8.16x

IDYA3.01x

P/FCF Ratio

CDNA39.14x

IDYAN/A

EV/FCF

CDNA34.70x

IDYA-27.76x

PEG Ratio

CDNA0.31x

IDYAN/A

Forward P/E (NTM)

CDNA57.50x

IDYAN/A

Forward P/S (NTM)

CDNA6.55x

IDYA59.38x

Revenue (TTM)

CDNA$458M

IDYA$234M

Revenue Growth (YoY)

CDNA34.4%

IDYA3244.7%

Forward Rev Growth

CDNA7.0%

IDYA218.2%

Gross Margin (TTM)

CDNA70.6%

IDYA0.0%

Operating Margin (TTM)

CDNA23.6%

IDYA0.0%

EBITDA Margin (TTM)

CDNA27.4%

IDYA-91.5%

Net Margin (TTM)

CDNA24.2%

IDYA-74.8%

FCF Margin (TTM)

CDNA18.3%

IDYA-48.6%

Net Income (TTM)

CDNA$111M

IDYA$-175M

FCF (TTM)

CDNA$84M

IDYA$-114M

EPS (TTM)

CDNA$2.08

IDYA-$1.90

ROE (TTM)

CDNA32.8%

IDYA-1647.0%

ROA (TTM)

CDNA24.8%

IDYA-1511.0%

ROIC (TTM)

CDNA32.8%

IDYA-1647.0%

Cash

CDNA$374M

IDYA$273M

Debt

CDNA$0

IDYA$0

Net Cash/Debt

CDNA$374M

IDYA$273M

Current Ratio (TTM)

CDNA4.58x

IDYA10.45x

Quick Ratio (TTM)

CDNA4.35x

IDYA10.21x

Debt/Equity (TTM)

CDNA0.00x

IDYA0.00x

Debt/Assets (TTM)

CDNA0.0%

IDYA0.0%

Interest Coverage (TTM)

CDNAN/A

IDYAN/A

Net Debt/EBITDA (TTM)

CDNA0.00x

IDYA0.00x

Beta

CDNA2.58

IDYA0.04

52W Performance

CDNA330.5%

IDYA34.5%

YTD Performance

CDNA232.7%

IDYA6.7%

% from 52W High

CDNA-12.2%

IDYA-15.4%

% from 52W Low

CDNA356.4%

IDYA38.6%

Asset Turnover (TTM)

CDNA1.02x

IDYA0.20x

FCF Yield (TTM)

CDNA2.6%

IDYA-3.3%

Earnings Yield (TTM)

CDNA3.4%

IDYA-5.1%

Dividend Yield (TTM)

CDNAN/A

IDYAN/A

Rule of 40

CDNA52.7

IDYA3,196.0

EV/GP/RG

CDNA0.94

IDYAN/A

Ticker research

View CDNA research View IDYA research

Metric	CDNA CareDx Inc	IDYA IDEAYA Biosciences Inc
Market & Valuation
Market Cap	$3.29B	$3.43B
Enterprise Value	$2.92B	$3.16B
Price	$63.67	$36.11
P/E Ratio	30.64x	N/A
P/S Ratio	7.18x	14.66x
EV/Sales	6.36x	13.50x
EV/EBITDA	23.24x	0.00x
P/B Ratio	8.16x	3.01x
P/FCF Ratio	39.14x	N/A
EV/FCF	34.70x	-27.76x
PEG Ratio	0.31x	N/A
Forward P/E (NTM)	57.50x	N/A
Forward P/S (NTM)	6.55x	59.38x
Revenue & Growth
Revenue (TTM)	$458M	$234M
Revenue Growth (YoY)	34.4%	3244.7%
Forward Rev Growth	7.0%	218.2%
Profitability
Gross Margin (TTM)	70.6%	0.0%
Operating Margin (TTM)	23.6%	0.0%
EBITDA Margin (TTM)	27.4%	-91.5%
Net Margin (TTM)	24.2%	-74.8%
FCF Margin (TTM)	18.3%	-48.6%
Net Income (TTM)	$111M	$-175M
FCF (TTM)	$84M	$-114M
EPS (TTM)	$2.08	-$1.90
ROE (TTM)	32.8%	-1647.0%
ROA (TTM)	24.8%	-1511.0%
ROIC (TTM)	32.8%	-1647.0%
Financial Health
Cash	$374M	$273M
Debt	$0	$0
Net Cash/Debt	$374M	$273M
Current Ratio (TTM)	4.58x	10.45x
Quick Ratio (TTM)	4.35x	10.21x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.58	0.04
52W Performance	330.5%	34.5%
YTD Performance	232.7%	6.7%
% from 52W High	-12.2%	-15.4%
% from 52W Low	356.4%	38.6%
Efficiency & Yields
Asset Turnover (TTM)	1.02x	0.20x
FCF Yield (TTM)	2.6%	-3.3%
Earnings Yield (TTM)	3.4%	-5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	52.7	3,196.0
EV/GP/RG	0.94	N/A
Ticker research	View CDNA research	View IDYA research